Skip to Content

472 (Imatinib Mesylate 100 mg)

Pill with imprint 472 is Yellow, Round and has been identified as Imatinib Mesylate 100 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 472

Imatinib Mesylate

Imprint
472
Strength
100 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharma Global FZE
National Drug Code (NDC)
47335-0472
Inactive Ingredients
microcrystalline cellulose, mannitol, copovidone, crospovidone, magnesium stearate, hypromelloses, ferric oxide yellow, polyethylene glycol, titanium dioxide, FD&C Yellow No. 6, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "472"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.